National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 34582-34583 [E9-16830]
Download as PDF
<![CDATA[
34582
Federal Register / Vol. 74, No. 135 / Thursday, July 16, 2009 / Notices
Proposed Collection: Title: An
Outcome Evaluation of the NIH
Director’s Pioneer Award (NDPA)
Program. Type of Information Collection
Request: New collection. Need and Use
of Information Collection: This study
will assess the NDPA Program outputs
and outcomes. The primary objectives of
the study are to assess: (1) Whether the
NDPA awardees are conducting
pioneering research, (2) whether there
are spillover effects on the awardees,
their lab members, NIH, and the
scientific community, and (3) to follow
the careers and ideas proposed by
NDPA unfunded applicants. The
findings will provide valuable
information concerning the success of
the awardees (pioneers) and whether the
characteristics of the NDPA program are
adopted by other NIH programs.
Frequency of Response: Once.
Affected Public: none. Type of
Respondents: Applicants, Unfunded
Applicants, Pioneer Lab Members,
Focus Group Panelists. There are no
Capital Costs to report. Estimated
Number of Respondents: 50, Estimated
Number of Responses per Respondent:
1: Average Burden Hours Per Response:
2.14 (60 minutes for awardees, 15
minutes for unfunded applicants, 30
minutes for pioneer lab members, and
10 hours for focus group panelists).
Estimated Total Annual Burden Hours
Requested: 284.5 and the annualized
cost to respondents is estimated at
$18,181.72. Table l and Table 2,
respectively, present data concerning
the burden hours and cost burdens for
this data collection.
TABLE 1—ANNUALIZED ESTIMATE OF HOUR BURDEN
Type of
respondents
Number of respondents
Average time
for response
(hr)
Frequency of
response
Total hour
burden*
Awardees (Pioneers) ...................................................................................
Unfunded Applicants ....................................................................................
Pioneer Lab Members .................................................................................
Expert Panel ................................................................................................
22
440
25
14
1
1
1
1
1.0
0.25
0.5
10.0
22.0
110.0
12.5
140.0
Total ......................................................................................................
501
1
.56
284.5
Total Burden = N Respondents*Response Frequency*(minutes to complete/60).
TABLE 2—ANNUALIZED COST TO RESPONDENTS
Number of
respondents
Type of respondents
Response
frequency
Approx. hourly
wage rate
Total respondent cost**
Awardees .........................................................................................................
Unfunded Applicants ........................................................................................
Pioneer Lab Members .....................................................................................
Focus Group Panel ..........................................................................................
22
440
25
14
1
1
1
1
$64.72
64.72
46.23
64.72
$1,423.84
7119.20
577.88
9,060.80
Total ..........................................................................................................
501
1
63.59
18,181.72
erowe on DSK5CLS3C1PROD with NOTICES
**Total Respondent Cost = Total Hour Burden * Hourly Wage Rate.
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Whether the proposed collection of
information is necessary for the proper
performance of the function of the
agency, including whether the
information will have practical utility;
(2) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information, including the validity of
the methodology and assumptions used;
(3) ways to enhance the quality, utility,
and clarity of the information to be
collected; and (4) ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
VerDate Nov<24>2008
15:08 Jul 15, 2009
Jkt 217001
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs (OIRA). All
comments should be sent via email to
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974. Attention: Desk
Office for NIH. To request more
information on the project or to obtain
a copy of the data collection plans and
instruments contact G. Stephane
Philogene, Ph.D., Assistant Director for
Policy and Planning, Office of
Behavioral and Social Sciences
Research, National Institutes of Health,
31 Center Drive. Building 31, Room B2–
B37 Bethesda, MD 20892, or call nontoll-free number (301) 402–3902 or Email your request, including your
address to: philoges@od.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Dated: July 9, 2009.
G. Stephane Philogene,
Assistant Director for Policy and Planning,
Office of Behavioral and Social Sciences
Research, National Institutes of Health.
[FR Doc. E9–16835 Filed 7–15–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended.
The contract proposals and the
discussions could disclose confidential
E:\FR\FM\16JYN1.SGM
16JYN1
Federal Register / Vol. 74, No. 135 / Thursday, July 16, 2009 / Notices
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Animal Models of Infectious
Diseases 2.
Date: July 29–31, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Crowne Plaza Hotel—Silver Spring,
8777 Georgia Avenue, Lincoln Ballroom,
Silver Spring, MD 20910.
Contact Person: Tracy A. Shahan, PhD,
MBA, Scientific Review Officer, Scientific
Review Program, NIH/NIAID/DHHS, Room
3121, 6700B Rockledge Drive, MSC 7616,
Bethesda, MD 20892–7616, 301–451–2606,
tshahan@niaid.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Ancillary Studies in
Immunomodulation Clinical Trials.
Date: August 12, 2009.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817
(Telephone Conference Call).
Contact Person: Paul A. Amstad, PhD,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIAID/NIH/DHHS, 6700B Rockledge Drive,
MSC 7616, Bethesda, MD 20892–7616, 301–
402–7098, pamstad@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: July 9, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–16830 Filed 7–15–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
erowe on DSK5CLS3C1PROD with NOTICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
VerDate Nov<24>2008
15:08 Jul 15, 2009
Jkt 217001
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Molecular Mechanisms of
HIV Latency.
Date: August 17, 2009.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Room 3133, Bethesda, MD
20817 (Telephone Conference Call).
Contact Person: Jay Bruce Sundstrom, PhD,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, Room
2217, 6700B Rockledge Drive, MSC–7616,
Bethesda, MD 20892–7616, 301–496–2550,
sundstromj@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: July 9, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–16831 Filed 7–15–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel, July
22, 2009, 8 a.m.to July 23, 2009, 5 p.m.,
Marriott Bethesda North Hotel &
Conference Center, Bethesda, MD which
was published in the Federal Register
on June 11, 2009, 74FR27806.
This notice is amended to change the
title from ‘‘NCI–ARRA Competitive
Revisions-Pre Clinical, Drug Discovery
& Imaging’’ to ‘‘NCI–ARRA Competitive
Revisions & Grand Opportunity-Pre
Clinical, Drug Discovery & Imaging’’.
The meeting is closed to the public.
Dated: July 9, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–16894 Filed 7–15–09; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
34583
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Skeletal
Muscle Biology and Exercise Physiology
Competitive Revisions.
Date: July 23–27, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Priscilla B. Chen, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4104,
MSC 7814, Bethesda, MD 20892, (301) 435–
1787, chenp@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Skeletal
Biology I ARRA CR.
Date: July 23–26, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Daniel F. McDonald, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4110,
MSC 7814, Bethesda, MD 20892, (301) 435–
1215, mcdonald@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Skeletal
Biology II ARRA CR.
Date: July 23–26, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\16JYN1.SGM
16JYN1
]]>Agencies
[Federal Register Volume 74, Number 135 (Thursday, July 16, 2009)]
[Notices]
[Pages 34582-34583]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-16830]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended.
The contract proposals and the discussions could disclose confidential
[[Page 34583]]
trade secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the
contract proposals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Animal Models of Infectious
Diseases 2.
Date: July 29-31, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract proposals.
Place: Crowne Plaza Hotel--Silver Spring, 8777 Georgia Avenue,
Lincoln Ballroom, Silver Spring, MD 20910.
Contact Person: Tracy A. Shahan, PhD, MBA, Scientific Review
Officer, Scientific Review Program, NIH/NIAID/DHHS, Room 3121, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616, 301-451-2606,
tshahan@niaid.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Ancillary Studies in
Immunomodulation Clinical Trials.
Date: August 12, 2009.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6700B Rockledge Drive,
Bethesda, MD 20817 (Telephone Conference Call).
Contact Person: Paul A. Amstad, PhD, Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities, NIAID/
NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616,
301-402-7098, pamstad@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: July 9, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-16830 Filed 7-15-09; 8:45 am]
BILLING CODE 4140-01-P
